GP5 and B-cell chronic lymphocytic leukemia: Standardised delta scale Cochran–Mantel–Haenszel statistics calculated across cancer sites showed large DIF (≥ 1.5) between some sites (e.g. HCC, melanoma, CLL); however, there was no overall and consistent pattern of large DIF for GP5 across cancer sites (Table 4).